---
schema_version: "secwatch.filing_event.v1"
accession: "0001428336-24-000005"
form_type: "8-K"
ticker: "HQY"
cik: "0001428336"
company_name: "HEALTHEQUITY, INC."
filed_at: "2024-02-21T23:59:59+00:00"
generated_at: "2026-06-05T21:55:06.609965+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# HealthEquity reports 9% HSA growth to 8.7M accounts, raises FY24 guidance, affirms FY25 outlook

## Summary
- HSAs 8.69M (+9% YoY); HSA Assets $25.2B (+14%); Total Accounts 15.7M (+5%).
- Q4 new HSAs from sales 497K (+12% YoY); record organic growth.
- FY24 guidance raised: Revenue $995M-$1B, Non-GAAP EPS $2.20-$2.24.
- FY25 guidance reaffirmed: Revenue $1.14B-$1.16B, Adj. EBITDA margin 38%-39%.
- CFO targets doubling non-GAAP EPS over three years as HSA cash yields rise.

## SEC filing metadata
- accession: 0001428336-24-000005
- form_type: 8-K
- ticker: HQY
- cik: 0001428336
- company_name: HEALTHEQUITY, INC.
- filed_at: 2024-02-21T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1428336/000142833624000005/0001428336-24-000005-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1428336/000142833624000005/hqy-20240221.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001428336-24-000005
- JSON: https://secwatch.observer/filing/0001428336-24-000005.json
- Plain text: https://secwatch.observer/filing/0001428336-24-000005.txt

## Key facts
- Earnings Releases
  HEALTHEQUITY, INC. reported the fiscal year ending January 31, 2025 results: revenue $1.140 billion to $1.160 billion. Guidance reaffirmed.
  - Period: the fiscal year ending January 31, 2025
  - Revenue: $1.140 billion to $1.160 billion
  - Guidance: reaffirmed
  - Result: guidance update
  source text: For the fiscal year ending January 31, 2025, the Company affirmed its previously provided outlook, which assumes an average annualized yield on HSA cash of approximately 3%, as follows: • Revenue in the range of $1.140 billion to $1.160 billion;
  evidence_url: https://www.sec.gov/Archives/edgar/data/1428336/000142833624000005/0001428336-24-000005-index.htm
- Earnings Releases
  HEALTHEQUITY, INC. reported the fiscal year ended January 31, 2024 results: revenue $995 million to $1 billion, net income $49 million to $52 million, EPS $0.56 to $0.60. Guidance raised.
  - Period: the fiscal year ended January 31, 2024
  - Revenue: $995 million to $1 billion
  - Net income: $49 million to $52 million
  - EPS: $0.56 to $0.60
  - Guidance: raised
  - Result: guidance update
  source text: For the fiscal year ended January 31, 2024, the Company revised its previously provided outlook as follows: • Revenue in the range of $995 million to $1 billion; • Net income in the range of $49 million to $52 million; • Net income per diluted share in the range of $0.56 to $0.60;
  evidence_url: https://www.sec.gov/Archives/edgar/data/1428336/000142833624000005/0001428336-24-000005-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.